Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
53.92 AUD | -0.70% | -2.65% | +2.51% |
Mar. 11 | Australian shares fall as miners, banks weigh | RE |
Feb. 28 | Ramsay Health Care Posts 14% Rise in H1 FY24 Revenue | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
Weaknesses
- The company does not generate enough profits, which is an alarming weak point.
- The company is in debt and has limited leeway for investment
- The company benefits from high valuations in earnings multiples.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+2.51% | 8.2B | A- | ||
-11.31% | 18.1B | B+ | ||
-10.37% | 15.33B | A- | ||
+4.50% | 12.84B | B | ||
+1.00% | 11.38B | B+ | ||
+7.58% | 10.38B | B+ | ||
+13.89% | 7.49B | B | ||
+8.89% | 6.9B | B- | ||
+6.98% | 6.45B | D | ||
+6.17% | 4.7B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock
- Equities
- Stock Ramsay Health Care Limited - Australian S.E.
- Ratings Ramsay Health Care Limited